Day: January 1, 2022

Testing for MPS Disease Management

WHAT ARE MUCOPOLYSACCHARIDOSIS (MPS) DISORDERS? A: MPS disorders are characterized by abnormal glycosaminoglycan (GAG) accumulation resulting from deficiencies or malfunctions of enzymes involved in GAG degradation. These disorders are clinically heterogeneous and characterized by multi-systemic manifestations, including abnormal GAG accumulation-associated skeletal abnormalities…Read More »